Lbp Am Sa Grows Stock Position in The Cooper Companies, Inc. $COO

Lbp Am Sa lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 79.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 125,325 shares of the medical device company’s stock after purchasing an additional 55,391 shares during the quarter. Lbp Am Sa owned about 0.06% of Cooper Companies worth $8,918,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Cooper Companies by 15.1% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company’s stock worth $2,194,000 after purchasing an additional 3,440 shares during the last quarter. DAVENPORT & Co LLC raised its position in Cooper Companies by 13.4% in the first quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company’s stock worth $366,000 after acquiring an additional 513 shares in the last quarter. Cerity Partners LLC raised its position in Cooper Companies by 6.6% in the first quarter. Cerity Partners LLC now owns 17,113 shares of the medical device company’s stock worth $1,443,000 after acquiring an additional 1,054 shares in the last quarter. State of Alaska Department of Revenue raised its position in Cooper Companies by 3.0% in the first quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company’s stock worth $1,972,000 after acquiring an additional 680 shares in the last quarter. Finally, United Services Automobile Association purchased a new position in Cooper Companies in the first quarter worth $414,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Down 0.7%

Cooper Companies stock opened at $68.07 on Thursday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The firm has a market capitalization of $13.53 billion, a price-to-earnings ratio of 33.53, a price-to-earnings-growth ratio of 1.80 and a beta of 1.02. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $109.37. The stock’s fifty day moving average is $69.86 and its two-hundred day moving average is $74.30.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. The business had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies announced that its Board of Directors has initiated a share repurchase program on Wednesday, September 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the medical device company to purchase up to 15.4% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its shares are undervalued.

Insider Buying and Selling at Cooper Companies

In related news, CEO Albert G. White III acquired 10,000 shares of the firm’s stock in a transaction that occurred on Friday, September 5th. The shares were acquired at an average price of $68.39 per share, with a total value of $683,900.00. Following the completion of the purchase, the chief executive officer directly owned 226,151 shares in the company, valued at approximately $15,466,466.89. The trade was a 4.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Brian G. Andrews acquired 1,525 shares of the firm’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were bought at an average cost of $65.68 per share, for a total transaction of $100,162.00. Following the purchase, the executive vice president owned 22,191 shares of the company’s stock, valued at approximately $1,457,504.88. The trade was a 7.38% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 17,975 shares of company stock valued at $1,216,346. 1.98% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts have issued reports on COO shares. JPMorgan Chase & Co. cut their price objective on Cooper Companies from $76.00 to $66.00 and set a “neutral” rating for the company in a research report on Thursday, August 28th. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 price objective on shares of Cooper Companies in a research report on Thursday, August 28th. Wall Street Zen cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. Piper Sandler cut their price objective on Cooper Companies from $105.00 to $83.00 and set an “overweight” rating for the company in a research report on Thursday, August 28th. Finally, BNP Paribas Exane raised Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 target price on the stock in a report on Tuesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $84.75.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.